Accretive Wealth Partners’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.05M Buy
3,863
+681
+21% +$195K 0.3% 84
2025
Q4
$916K Hold
3,182
0.27% 87
2025
Q3
$826K Hold
3,182
0.25% 93
2025
Q2
$790K Hold
3,182
0.26% 95
2025
Q1
$780K Hold
3,182
0.28% 95
2024
Q4
$807K Hold
3,182
0.34% 88
2024
Q3
$898K Hold
3,182
0.38% 89
2024
Q2
$846K Hold
3,182
0.35% 89
2024
Q1
$821K Hold
3,182
0.36% 88
2023
Q4
$798K Hold
3,182
0.38% 89
2023
Q3
$748K Hold
3,182
0.45% 74
2023
Q2
$779K Hold
3,182
0.46% 73
2023
Q1
$759K Hold
3,182
0.49% 69
2022
Q4
$789K Hold
3,182
0.54% 56
2022
Q3
$712K Hold
3,182
0.54% 59
2022
Q2
$749K Hold
3,182
0.54% 60
2022
Q1
$809K Hold
3,182
0.51% 72
2021
Q4
$848K Hold
3,182
0.54% 73
2021
Q3
$786K Sell
3,182
-300
-9% -$77K 0.55% 71
2021
Q2
$861K Buy
3,482
+720
+26% +$172K 0.62% 66
2021
Q1
$632K Hold
2,762
0.57% 79
2020
Q4
$618K Buy
+2,762
New +$590K 0.61% 71

Other funds holding VHT

Accretive Wealth Partners's VHT Position: Q1 2026 in Review

Accretive Wealth Partners increased its Vanguard Health Care ETF (VHT) stake by 21% in Q1 2026, buying an estimated $195K and bringing the position to 3,863 shares worth $1.05M. The position accounts for 0.3% of the portfolio, ranked #84.

Accretive Wealth Partners first reported a position in VHT in Q4 2020 and has held it in 22 quarters since. 1,085 funds tracked by Wall St. Rank hold VHT as of Q1 2026.

  • Accretive Wealth Partners held 3,863 shares of Vanguard Health Care ETF worth $1.05M as of Q1 2026.
  • Accretive Wealth Partners bought 681 Vanguard Health Care ETF shares in Q1 2026, an estimated $195K.
  • Vanguard Health Care ETF made up 0.3% of Accretive Wealth Partners's portfolio in Q1 2026, its #84 holding.
  • Accretive Wealth Partners first reported a position in Vanguard Health Care ETF in Q4 2020 and has held it in 22 quarters since.
  • 1,085 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q1 2026.

Based on Accretive Wealth Partners's 13F filing for Q1 2026, filed 22 Apr 2026.